McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) Return on equity
McKesson Corporation's return on equity over the twelve months to 30 June 2026 was −168.5%, up 105.9 percentage points from fiscal 2026 (−274.4%). Over the past ten years it has ranged from −274.4% (fiscal 2026) to 50.0% (fiscal 2017) — the current reading is the lowest in ten years. That is below the Medical Distribution industry median of 0.00% and below the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | −274.4% | (74.27) |
| FY2025 | −200.1% | (5.75) |
| FY2024 | −194.4% | 22.57 |
| FY2023 | −216.9% | (79.15) |
| FY2022 | −137.8% | 27.75 |
| FY2021 | −165.5% | (178.78) |
| FY2020 | 13.2% | 12.87 |
| FY2019 | 0.37% | (0.26) |
| FY2018 | 0.63% | (49.37) |
| FY2017 | 50.0% | 23.58 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| COR Cencora, Inc. compare | 96.3% |
| ACH Accendra Health, Inc. compare | 72.6% |
| HSIC Henry Schein, Inc. compare | 10.2% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| CAH Cardinal Health, Inc. compare | −64.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation | −168.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MCK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement